{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Evaluate+the+Safety&page=5", "query": { "condition": "Evaluate the Safety", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 11986, "total_pages": 1199, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Evaluate+the+Safety&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Evaluate+the+Safety&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T11:23:16.240Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01447407", "title": "Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Staphylococcal Infections", "Yeast Infections", "Candidiasis" ], "interventions": [ { "name": "NDV-3 vaccine with alum IM", "type": "BIOLOGICAL" }, { "name": "NDV-3 vaccine without alum IM", "type": "BIOLOGICAL" }, { "name": "Placebo with alum IM", "type": "BIOLOGICAL" }, { "name": "NDV-3 vaccine without alum ID", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "NovaDigm Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 164, "start_date": "2011-09", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2020-03-04", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01447407" }, { "nct_id": "NCT01428492", "title": "Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "GSK2110183", "type": "DRUG" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2011-12", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2018-08-08", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 8, "location_summary": "Scottsdale, Arizona • Duarte, California • Atlanta, Georgia + 5 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01428492" }, { "nct_id": "NCT07392372", "title": "A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV -1 Infection" ], "interventions": [ { "name": "BNT351", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 67, "start_date": "2026-02-09", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 4, "location_summary": "Chicago, Illinois • Baltimore, Maryland • St Louis, Missouri + 1 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07392372" }, { "nct_id": "NCT01959412", "title": "Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol 27.5 mcg", "type": "DRUG" }, { "name": "Indacaterol 37.5", "type": "DRUG" }, { "name": "Indacaterol 55 mcg", "type": "DRUG" }, { "name": "Indacaterol 75 mcg", "type": "DRUG" }, { "name": "Indacaterol 150 mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 91, "start_date": "2013-11", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2015-05-06", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 12, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 9 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01959412" }, { "nct_id": "NCT06259981", "title": "A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "GLY-200", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glyscend, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 75, "start_date": "2024-05-20", "completion_date": "2024-10-23", "has_results": false, "last_update_posted_date": "2025-01-23", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 5, "location_summary": "Clearwater, Florida • Ocoee, Florida • Marrero, Louisiana + 2 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Ocoee", "state": "Florida" }, { "city": "Marrero", "state": "Louisiana" }, { "city": "Butte", "state": "Montana" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06259981" }, { "nct_id": "NCT00451867", "title": "A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Interstitial Cystitis", "Painful Bladder Syndrome" ], "interventions": [ { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Mycofenolate Mofetil (MMF)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2007-03", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2010-01-14", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 10, "location_summary": "San Diego, California • Stanford, California • Maywood, Illinois + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Maywood", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00451867" }, { "nct_id": "NCT00612534", "title": "A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post Operative Pain" ], "interventions": [ { "name": "Sufentanil NanoTab", "type": "DRUG" }, { "name": "Placebo NanoTab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Talphera, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "45 Years to 80 Years" }, "enrollment_count": 94, "start_date": "2008-03", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2014-02-17", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00612534" }, { "nct_id": "NCT07132775", "title": "Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis", "Fibromyalgia", "Neurologic Disorder", "Neuromuscular Disorders" ], "interventions": [ { "name": "Active full-body stimulation", "type": "DEVICE" }, { "name": "Sham full-body stimulation", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Shirley Ryan AbilityLab", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 15, "start_date": "2025-07-23", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07132775" }, { "nct_id": "NCT05675930", "title": "A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft-Versus-Host Disease", "GVHD", "Undefined" ], "interventions": [ { "name": "Photobiomodulation Therapy", "type": "DEVICE" }, { "name": "Placebo sham device", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 44, "start_date": "2022-12-22", "completion_date": "2026-12-22", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 9, "location_summary": "Bethesda, Maryland • Basking Ridge, New Jersey • Middletown, New Jersey + 6 more", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05675930" }, { "nct_id": "NCT00001992", "title": "A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "rgp120/HIV-1IIIB", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-22T11:23:16.240Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001992" } ] }